50 years of Anti-D celebrated at World Congress of Gynecology and Obstetrics in Rio De Janeiro
Kedrion supports educational symposium to help Rh disease awareness and eradication
EIGHT, the global educational initiative on Hemophilia A and its treatment
Experts from all over the world attended the EIGHT 2018 Conference in Budapest, Hungary on 12-13 October
Kedrion Biopharma participates in the Mother and Child Conference in Moscow
A 50 years of Anti-D dedicated programme presented at the main Russian congress of Gynecology and Obstetrics
Kedrion joins Rhesus Solution Initiative (RSI) symposium in Lagos
Nigeria to advocate for Rh Disease universal eradication
Kedrion Joins Annual PNS Conference on Neurology
The company took part in the event with a booth and a delegation of 40 int’l guests
Kedrion Biopharma celebrates Primary Immunodeficiency Week
The company stands alongside PI patients associations around the globe
Kedrion Biopharma celebrates World Hemophilia Day 2018
Support for patients with coagulation disorders worldwide is confirmed
50-Year Anniversary of a Maternal Health Breakthrough
Kedrion Biopharma supports session on Anti-D achievements and challenges at FIGO Congress in Dubai
Kedrion Biopharma runner up at the Premio Equita for the bond issued in July 2017
The prize is awarded to the companies that made the best use of the capital markets
Kedrion Biopharma joins Columbia University to celebrate 50 years of Anti-D
Since 1968, billions of babies have been saved from Hemolytic Disease of the Fetus and Newborn